FIELD: medicine.
SUBSTANCE: treating polycystic ovarian syndrome in adolescent girls having the normal body weight, however no metabolic-endocrine comorbidity and active and sub-compensated chronic extragenital diseases, with the use of non-hormonal preparations is ensured by prescribing two non-hormonal target herbal preparations from the first day of spontaneous or gestagen-induced menstruation: indinol 600 mg twice a day and epigallat 1,000 mg twice a day continuously over a period of 6 months.
EFFECT: normalising the menstruation rhythm in the adolescents, making it possible to recommend these preparations as an alternative to hormone therapy, especially provided combined oral contraceptives are contraindicated or rejected.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSTIC TECHNIQUE FOR POLYCYSTIC OVARIAN SYNDROME IN ADOLESCENTS BY MEASURING URINE 2-OHE1/16α-OHE1 RATIO | 2014 |
|
RU2574020C1 |
| METHOD FOR ASSESSING OVARIAN HEALTH IN TRANSRECTAL COMPLEX THREE-DIMENSIONAL ECHOGRAPHY IN VIRGINAL ADOLESCENT FEMALES SUFFERING FROM POLYCYSTIC OVARIAN SYNDROME | 2014 |
|
RU2574188C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF OVARIAN AND ADRENAL HYPERANDROGENISM IN GIRLS OF PUBERTY AGE | 2015 |
|
RU2592235C1 |
| METHOD OF DIAGNOSTICS OF MENSTRUAL DYSFUNCTION AGAINST BACKGROUND OF POLYCYSTIC OVARIAN SYNDROME BY IMMATURE GIRLS | 2013 |
|
RU2535096C1 |
| TREATMENT OF HEPATIC STEATOSIS RELATED OLIGO-OVULATION | 2016 |
|
RU2745606C2 |
| METHOD OF DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME IN YOUNG GIRLS | 1997 |
|
RU2134061C1 |
| METHOD FOR ESTIMATING DEGREE OF SEVERITY OF OVARIAN DYSFUNCTION IN GIRLS WITH PUBERAL HYPERANDROGENISM | 2018 |
|
RU2690502C1 |
| PHARMACEUTICAL COMPOSITION FOR ADENOMYOSIS TREATMENT AND PREVENTION | 2009 |
|
RU2406497C1 |
| METHOD FOR SELECTING THERAPEUTIC APPROACH TO FEMALE PATIENTS WITH OLIGOMENORRHEA AND OBESITY | 2014 |
|
RU2555347C1 |
| METHOD FOR TREATING CHRONIC ANOVULATION AND PREVENTING SYNDROME OF OVARIAN HYPERSTIMULATION | 1999 |
|
RU2201225C2 |
